PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bauer MP et al. – Currently, no evidence–based guidance can be given with respect to refractoriness to treatment and preventing recurrences after treatment for CDI. Results of clinical trials on new approaches with antimicrobials, immunotherapy or faecotherapy are urgently awaited.

   

Related Articles

Toxigenic Clostridium difficile colonization in children
Journal of Pediatric Infectious Diseases, 10/30/09    Relevance Score: 68%

Molecular Epidemiology of Clostridium difficile over the Course of 10 Years in a Tertiary Care Hospital
Clinical Infectious Diseases, 10/16/09    Relevance Score: 67%

Clostridium difficile-related death rates in Texas 1999-2005
Journal of Infection, 10/06/09    Relevance Score: 67%

Bacteriophage-Mediated Toxin Gene Regulation in Clostridium difficile
Journal of Virology, 11/09/09    Relevance Score: 66%

Use of International Classification of Diseases, Ninth Revision, Clinical Modification Codes and Medication Use Data to Identify Nosocomial Clostridium difficile Infection
Infection Control and Hospital Epidemiology, 10/14/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address